SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000935836-22-000176
Filing Date
2022-02-14
Accepted
2022-02-14 16:39:28
Documents
1
Group Members
ANUPAM DALAL

Document Format Files

Seq Description Document Type Size
1 catalyst13ga1.htm SC 13G/A 36312
  Complete submission text file 0000935836-22-000176.txt   38021
Mailing Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080 650-871-0761
CATALYST BIOSCIENCES, INC. (Subject) CIK: 0001124105 (see all company filings)

IRS No.: 562020050 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-82442 | Film No.: 22633371
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1301 SHOREWAY ROAD SUITE 350 BELMONT CA 94002
Business Address 1301 SHOREWAY ROAD SUITE 350 BELMONT CA 94002 650-529-8000
ACUTA CAPITAL PARTNERS, LLC (Filed by) CIK: 0001582844 (see all company filings)

IRS No.: 452817402 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A